Logo

DNA Script: Patrick Eimerman, John Luckey

Nov 05, 2019

Patrick Eimerman has been named global head of marketing and John Luckey has been appointed as VP for product development at DNA Script. Both will be based at the company's new US office. Eimerman joins DNA Script from Illumina, where he held senior sales and marketing roles. Prior to that, he was director of sales at GenomOncology and worked at Roche NimbleGen and DNA2.0. He holds a PhD in microbiology and immunology from Stanford University and a BS in bacteriology from the University of Wisconsin-Madison. Luckey comes to DNA Script from Thrive Bioscience, where he was VP of engineering and manufacturing. Before that, he held development roles at RainDance Technologies, Pathogenetix, Roche NimbleGen, and OpGen. Luckey holds PhD and MBA degrees from the University of Wisconsin-Madison and a BS from Stanford University.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.